Journal profile · Medicine-Cardiology and Cardiovascular Medicine
Cardiac Failure Review
ISSN 2057-7540 · eISSN 2057-7559 · Radcliffe Medical Media · United Kingdom
Cardiac Failure Review: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 12.2 (journal website); fully open access; APC charged, amount not published; median 72 days to acceptance (66 articles, last 24 months); 36 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cardiac Failure Review is published by Radcliffe Medical Media and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Cardiac pacing and defibrillation studies, together about 50.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiac Failure Review (CFR) is a Tri-Annual journal aimed at assisting heart failure specialists and cardiologists to stay abreast of key advances and opinion in the diagnosis, management and treatment of heart failure.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine
Editor-in-chief Andrew JSPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 6, Italy 2, Australia 2, United States 1, Sweden 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Heart Failure Treatment and ManagementMedicine25.3%
- Cardiovascular Function and Risk FactorsMedicine17.7%
- Cardiac pacing and defibrillation studiesMedicine7.5%
- Mechanical Circulatory Support DevicesEngineering5.5%
- Cardiac Structural Anomalies and RepairMedicine5.5%
- Diabetes Treatment and ManagementMedicine4.4%
- Cardiac Imaging and DiagnosticsMedicine3.4%
- Cardiac Valve Diseases and TreatmentsMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 12.2Publisher website ·
- CiteScore 2026-06
- 10LetPub ·
- SJR 2026-06
- 2.27LetPub ·
- SNIP 2026-06
- 2.4LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 177OpenAlex ·
- 2-year mean citedness
- 4.84OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 33LetPub ·
- Articles per year (publisher)
- 4Publisher website ·
Articles by year OpenAlex count · 328 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 33 | 13 |
| 2025 | 36 | 36 | 200 |
| 2024 | 20 | 20 | 218 |
| 2023 | 14 | 14 | 870 |
| 2022 | 36 | 36 | 752 |
| 2021 | 23 | 23 | 436 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
72 daysMedian, submission to acceptance · P25–P75 46 days – 106 days
- Acceptance to online
- median 97 days (66 articles)
- Submission to online
- median 177 days
- Sample
- 66 articles with submission and acceptance dates (71 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to first decision
- 35 daysPublisher website ·
- Submission to final decision
- 63 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,750 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 1,750 | — | — | |
| LetPub | GBP 1,750 | Yes | — | |
| Publisher website | GBP 1,750 / EUR 2,069 / USD 2,299 / GBP 3,300 / EUR 3,816 / USD 4,426 / GBP 3,900 / EUR 4,508 / USD 5,232 / GBP 2,600 / EUR 3,005 / USD 3,488 / GBP 1,500 / EUR 1,770 / USD 1,970 / GBP 2,000 / EUR 2,420 / USD 2,550 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Keywords
- 3–7
Article types accepted6, with length limits
- case reportve services available. Submission types Case Reports: 1,500 - 3,000 words excl abstract & refs. Max. 50 references. Editorial: 1500 -main text ≤ 3,000 words
- editorialcl abstract & refs. Max. 50 references. Editorial: 1500 - 2000 words excl abstract & refs. Max. 15 references. Editorials are bymain text ≤ 2,000 words
- letterexcl abstract & ref. Max. 20 references Letter: 1500 words. Max 10 references. Review Article: 2,500 – 5,000 words excmain text ≤ 1,500 words
- opinionitorials are by invitation only. Expert Opinion: 1,500 – 2500 words excl abstract & ref. Max. 20 references Letter: 1500 words.main text ≤ 2,500 words
- original researchxcl abstract & ref. Max. 80 references. Original Research: 2,500 – 5,000 words excl abstract & Ref. Max 100 references. Articles submittedmain text ≤ 5,000 words
- review articleLetter: 1500 words. Max 10 references. Review Article: 2,500 – 5,000 words excl abstract & ref. Max. 80 references. Original Research:main text ≤ 5,000 words
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Radcliffe Medical Media
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2057-7540
- Electronic ISSN
- 2057-7559
- Society / sponsor
- Italian Heart Failure Association
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardiac Failure Review
What CAS zone is Cardiac Failure Review in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiac Failure Review is in Zone 2 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiac Failure Review?
The journal's website gives an impact factor of 12.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 10, h-index 43.
How long does peer review take at Cardiac Failure Review?
Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 46–106 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cardiac Failure Review based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (6), Italy (2) and Australia (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiac Failure Review?
According to LetPub and DOAJ records, Cardiac Failure Review is indexed in ESCI, Scopus and DOAJ.
Is Cardiac Failure Review open access, and what is the APC?
Cardiac Failure Review is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .